Copperhead and Cottonmouth Envenomation Medication

1. Wingert WA, Pattabhiraman TR, Cleland R, Meyer P, Pattabhiraman R, Russell FE. Distribution and pathology of copperhead (agkistrodon contortrix) venom. Toxicon. 1980. 18(5-6):591-601. [QxMD MEDLINE Link].

2. O'Neil ME, Mack KA, Gilchrist J, Wozniak EJ. Snakebite injuries treated in United States emergency departments, 2001-2004. Wilderness Environ Med. 2007 Winter. 18 (4):281-7. [QxMD MEDLINE Link].

3. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018 Dec. 56 (12):1213-1415. [QxMD MEDLINE Link].

4. Sullivan JB, Wingert WA, Norris RL Jr. North American venomous reptile bites. PS Auerbach, ed. Wilderness Medicine: Management of Wilderness and Environmental Emergencies. St. Louis: Mosby-Year Book; 1995. Vol 2: 680-709.

5. Thorson A, Lavonas EJ, Rouse AM, Kerns WP 2nd. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003. 41(1):29-35. [QxMD MEDLINE Link].

6. World Health Organization. Prevalence of snakebite envenoming. Available at https://www.who.int/snakebites/epidemiology/en/. Accessed: March 22, 2019.

7. Bush SP, Thomas TL, et al. Envenomations in children. Pediatr Emerg Med Rep. 1997. 2:1-12.

8. Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, et al. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Ann Emerg Med. 2017 Aug. 70 (2):233-244.e3. [QxMD MEDLINE Link].

9. Anderson VE, Gerardo CJ, Rapp-Olsson M, Bush SP, Mullins ME, Greene S, et al. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients. Clin Toxicol (Phila). 2019 Jan. 57 (1):25-30. [QxMD MEDLINE Link].

10. Thorson A, Lavonas EJ, Rouse AM, Kerns WP 2nd. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003. 41 (1):29-35. [QxMD MEDLINE Link].

11. Scharman EJ, Noffsinger VD. Copperhead snakebites: clinical severity of local effects. Ann Emerg Med. 2001 Jul. 38(1):55-61. [QxMD MEDLINE Link].

12. Toschlog EA, Bauer CR, Hall EL, Dart RC, Khatri V, Lavonas EJ. Surgical considerations in the management of pit viper snake envenomation. J Am Coll Surg. 2013 Oct. 217 (4):726-35. [QxMD MEDLINE Link].

13. Bush SP, Hegewald KG, Green SM, Cardwell MD, Hayes WK. Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. Wilderness Environ Med. 2000 Fall. 11(3):180-8. [QxMD MEDLINE Link].

14. Bush SP. Snakebite suction devices don't remove venom: they just suck. Ann Emerg Med. 2004 Feb. 43(2):187-8. [QxMD MEDLINE Link].

15. Burch JM, Agarwal R, Mattox KL, Feliciano DV, Jordan GL Jr. The treatment of crotalid envenomation without antivenin. J Trauma. 1988 Jan. 28(1):35-43. [QxMD MEDLINE Link].

16. Whitley RE. Conservative treatment of copperhead snakebites without antivenin. J Trauma. 1996 Aug. 41(2):219-21. [QxMD MEDLINE Link].

17. Lavonas EJ, Ruha AM, Banner W, Bebarta V, Bernstein JN, Bush SP, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011 Feb 3. 11:2. [QxMD MEDLINE Link]. [Full Text].

18. Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W Jr, et al. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004 Feb. 43(2):200-6. [QxMD MEDLINE Link].

19. Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997 Jul. 30(1):33-9. [QxMD MEDLINE Link].

20. Anderson VE, Gerardo CJ, Lavonas EJ, Olsson MR, Kleinschmidt KC, Sharma K, et al. Antivenom administration wa associated with shorter opioid use in copperhead snakebite patients [abstract]. Toxicon. 2018. 150:325.

21. Bush SP, Ruha AM, Seifert SA, Morgan DL, Lewis BJ, Arnold TC, et al. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol (Phila). 2015 Jan. 53 (1):37-45. [QxMD MEDLINE Link].

22. CroFab Dosing and Administration [package insert]. BTG International. 2018. Available at [Full Text].

23. ANAVIP Dosing Information [package insert]. Tlalpan CDMX, Mexico: Instituto Bioclon S.A. de C.V. June 2018. Available at [Full Text].

24. Pham HX, Mullins ME. Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients. Clin Toxicol (Phila). 2018 May 18. 1-7. [QxMD MEDLINE Link].

25. Lavonas EJ, Gerardo CJ. Letter to the editor: "Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients" by Pham and Mullins, Clin Toxicol 2018 May 18. Clin Toxicol (Phila). 2019 Feb. 57 (2):144-145. [QxMD MEDLINE Link].

26. Jurkovich GJ, Luterman A, McCullar K, et al. Complications of Crotalidae Antivenin Therapy. Journal of Trauma. 1998. 28:1032-1037.

27. Mullins ME, Gerardo CJ, Bush SP, Rose SR, Greene S, Quackenbush EB, et al. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial. South Med J. 2018 Dec. 111 (12):716-720. [QxMD MEDLINE Link].

28. Schaeffer TH, Khatri V, Reifler LM, Lavonas EJ. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Acad Emerg Med. 2012 Feb. 19 (2):121-31. [QxMD MEDLINE Link].

Sean P Bush, MD, FACEP Professor of Emergency Medicine, The Brody School of Medicine at East Carolina University

Sean P Bush, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, International Society on Toxicology, Society for Academic Emergency Medicine, Wilderness Medical Society

Disclosure: Nothing to disclose.

Eric J Lavonas, MD, FACEP Associate Director, Rocky Mountain Poison and Drug Center; Assistant Professor, University of Colorado School of Medicine

Eric J Lavonas, MD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Clinical Toxicology, Phi Beta Kappa, American College of Emergency Physicians, American College of Medical Toxicology, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

David Eitel, MD, MBA Associate Professor, Department of Emergency Medicine, York Hospital; Physician Advisor for Case Management, Wellspan Health System, York

David Eitel, MD, MBA is a member of the following medical societies: American College of Emergency Physicians, American Society of Pediatric Nephrology, Society for Academic Emergency Medicine, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Joe Alcock, MD, MS Associate Professor, Department of Emergency Medicine, University of New Mexico Health Sciences Center

Joe Alcock, MD, MS is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Robert L Norris, MD Professor Emeritus, Department of Emergency Medicine, Stanford University Medical Center

Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, Wilderness Medical Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article